Shanghai Mabgeek Biotech.co.ltd

This study tests a new drug called MG-K10 in 180 teenagers with moderate-to-severe eczema that hasn't improved with creams. The drug is given as a shot and aims to clear skin and reduce itching. Participants will be randomly assigned to get the drug or a placebo, and neither they…

This study tests an injectable drug called MG-K10 in 226 people aged 12 to 75 who have had chronic hives for at least 6 months and still get itchy welts despite taking antihistamines. Participants will receive either the drug or a placebo for 24 weeks to see if it reduces itching…

This study tests an investigational drug called MG-K10 in about 498 adults and teenagers (age 12+) with moderate-to-severe atopic dermatitis (eczema) that hasn't improved with standard creams. Participants will receive either MG-K10 or a placebo injection to see if it reduces ski…